We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$553M
AUM Growth
+$21.4M
Cap. Flow
-$13.5M
Cap. Flow %
-2.43%
Top 10 Hldgs %
23.35%
Holding
124
New
1
Increased
20
Reduced
85
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$330K
2
CVGW
Calavo Growers
CVGW
+$265K
3
LH icon
Labcorp
LH
+$226K
4
BUD icon
AB InBev
BUD
+$181K
5
SLB icon
SLB Ltd
SLB
+$180K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.58M
2
GE icon
GE Aerospace
GE
+$1.54M
3
BA icon
Boeing
BA
+$1.17M
4
META icon
Meta Platforms (Facebook)
META
+$865K
5
AAPL icon
Apple
AAPL
+$783K

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 15.63%
3 Industrials 12.54%
4 Communication Services 12.1%
5 Consumer Staples 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
$7.84M 1.42%
108,254
+509
+0.5% +$35.9K
SLB icon
27
SLB Ltd
SLB
$73.6B
$7.83M 1.42%
116,663
+2,785
+2% +$180K
PG icon
28
Procter & Gamble
PG
$336B
$7.53M 1.36%
118,523
+563
+0.5% +$50.6K
XOM icon
29
ExxonMobil
XOM
$644B
$7.5M 1.36%
89,651
-2,669
-3% -$221K
SYY icon
30
Sysco
SYY
$40.8B
$7.28M 1.32%
120,141
-791
-0.7% -$44.8K
PFE icon
31
Pfizer
PFE
$143B
$7.22M 1.31%
210,251
-1,509
-0.7% -$51.5K
ABBV icon
32
AbbVie
ABBV
$443B
$7.04M 1.27%
72,785
-2,990
-4% -$282K
ENB icon
33
Enbridge
ENB
$119B
$6.93M 1.25%
177,944
+4,080
+2% +$157K
AMGN icon
34
Amgen
AMGN
$208B
$6.84M 1.24%
39,577
-662
-2% -$117K
BDX icon
35
Becton Dickinson
BDX
$45.6B
$6.75M 1.22%
32,308
-666
-2% -$139K
DE icon
36
Deere & Co
DE
$160B
$6.02M 1.09%
38,629
-1,149
-3% -$161K
SCHW
37
Charles Schwab
SCHW
$183B
$5.98M 1.08%
117,206
-3,083
-3% -$145K
ABT icon
38
Abbott
ABT
$183B
$5.83M 1.05%
102,132
-815
-0.8% -$45.2K
GLW icon
39
Corning
GLW
$119B
$5.43M 0.98%
169,916
-2,715
-2% -$85.5K
PX
40
DELISTED
Praxair Inc
PX
$5.22M 0.94%
56,792
-1,020
-2% -$151K
ZBH icon
41
Zimmer Biomet
ZBH
$18.2B
$4.81M 0.87%
41,321
-46
-0.1% -$5.2K
MKC icon
42
McCormick & Company Non-Voting
MKC
$13.7B
$4.81M 0.87%
94,334
-456
-0.5% -$22.7K
KR icon
43
Kroger
KR
$35.4B
$4.64M 0.84%
60,146
+1,698
+3% +$39.5K
CMI icon
44
Cummins
CMI
$87.5B
$4.48M 0.81%
25,673
+330
+1% +$56.4K
GOOGL icon
45
Alphabet (Google) Class A
GOOGL
$4.36T
$4.48M 0.81%
85,000
-9,180
-10% -$474K
CAT icon
46
Caterpillar
CAT
$375B
$4.47M 0.81%
28,374
-430
-1% -$59.6K
AXP icon
47
American Express
AXP
$227B
$4.42M 0.8%
44,890
-1,195
-3% -$114K
BUD icon
48
AB InBev
BUD
$170B
$4.42M 0.8%
40,025
+1,542
+4% +$181K
DT
49
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$4.36M 0.79%
248,981
+5,025
+2% +$87.9K
BMY icon
50
Bristol-Myers Squibb
BMY
$133B
$4.17M 0.75%
68,737
+961
+1% +$60.1K
1
2
3 4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs & Co held 124 positions worth $553M, up 4% from $532M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 2.4%. Jacobs & Co opened 1 new position and exited 2, leaving the 124-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2017 buy was Calavo Growers: 3,598 shares worth $303K.
  • Jacobs & Co added most to Celgene Corp in Q4 2017, an estimated $330K increase.
  • Jacobs & Co's biggest Q4 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.58M.
  • Jacobs & Co fully exited PG&E in Q4 2017, selling an estimated $347K.
  • Jacobs & Co's ten largest holdings make up 23% of its $553M portfolio in Q4 2017.
  • Jacobs & Co opened 1 new position and closed 2 in Q4 2017.
  • Jacobs & Co's portfolio value rose 4% quarter-over-quarter to $553M.

Based on Jacobs & Co's 13F filing for Q4 2017, filed 9 Feb 2018.